99mTc-(HE)3-(GPO)9 SPECT/CT imaging revealed significantly higher tracer uptake (0.65 %ID/mL) in the infarct zone of mice 2 weeks post-myocardial infarction compared to sham controls (0.34 %ID/mL).
99mTc-(HE)3-(GPO)9 enables noninvasive molecular imaging of denatured collagen, providing a potential biomarker for active collagen turnover and cardiac remodeling after myocardial infarction.
Absolute Event Rate: 0.65% vs 0.34%
p-value: p=<0.0001
Cardiac fibrosis is a key contributor to cardiomyopathy after myocardial infarction (MI). Existing imaging techniques can detect established fibrotic changes; however, they lack sensitivity for ongoing collagen turnover-a dynamic process involving the denaturation of collagen triple helix. Molecular imaging of this process could enhance risk assessment and aid in the development of antifibrotic treatments. This study aimed to evaluate 99mTc-(HE)3-(GPO)9, a radiotracer designed to target denatured collagen, as a biomarker of collagen turnover after MI. This tracer features a polyhistidine-glutamic acid (HE)3 N-terminal sequence for site-specific radiolabeling linked to a C-terminal-targeting moiety consisting of 9 glycine-proline-hydroxyproline repeats (GPO)9 via a flexible 3-glycine linker. Methods: MI was induced in mice by ligation of the left anterior descending artery; animals who underwent sham surgery served as controls. At 2 wk after MI, animals underwent myocardial perfusion imaging or contrast-enhanced CT to detect the infarct zone, followed by SPECT/CT imaging with 99mTc-(HE)3-(GPO)9 or a control tracer with scrambled peptide. Tracer uptake was quantified in vivo and ex vivo with γ-counting and autoradiography. Different aspects of fibrosis were examined using tissue analysis, along with autoradiography with a matrix metalloproteinase-targeted radiotracer, 99mTc-RYM1, at 3 d, 1 wk, and 2 wk after MI. Tracer binding was also assessed in human cardiac tissue using ex vivo autoradiography. Results: 99mTc-(HE)3-(GPO)9 SPECT/CT revealed significantly higher tracer uptake in the infarct zone of MI mice compared with the remote zone and sham controls (P ρ = 0.81, P 99mTc-(HE)3-(GPO)9 signal. Denatured collagen staining and 99mTc-RYM1 autoradiography showed patterns similar to that shown in ex vivo 99mTc-(HE)3-(GPO)9 autoradiography, whereas the ratio of denatured collagen to procollagen in the infarct zone significantly increased from day 3 to 2 wk after MI. Finally, 99mTc-(HE)3-(GPO)9 demonstrated binding to human fibrotic (but not normal) cardiac tissue. Conclusion: 99mTc-(HE)3-(GPO)9 enabled noninvasive detection of denatured collagen after MI as a marker of collagen remodeling in vivo. In combination with other fibrosis imaging tracers, 99mTc-(HE)3-(GPO)9 may provide a comprehensive molecular fingerprint of cardiac fibrosis, advancing personalized management of cardiomyopathy.
Neishabouri et al. (2026) studied Myocardial Infarction (n=47). 99mTc-(HE)3-(GPO)9 vs. Sham surgery was evaluated on Tracer uptake in the left ventricular wall by SPECT/CT (%ID/mL) (p=<0.0001). 99mTc-(HE)3-(GPO)9 SPECT/CT imaging revealed significantly higher tracer uptake (0.65 %ID/mL) in the infarct zone of mice 2 weeks post-myocardial infarction compared to sham controls (0.34 %ID/mL).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: